FDA approves Thermo Fisher’s Oncomine Dx Test to match HER2+ NSCLC patients with Boehringer Ingelheim’s HERNEXEOS.

Chikungunya has spread to 119 countries in 2025; Sino Biological supports vaccine, antiviral and diagnostic research.

Evolve Genomix is expanding genomic testing access, developing rapid diagnostics and securing NSF SBIR funding for innovation.

Thermo Fisher unveils two new electron microscopes designed to expand research access and productivity at M&M 2025.

Logical Biological launches Logical Antigen to accelerate custom antigen delivery for IVD research and diagnostics.

Spliceor receives CGT Catapult funding to develop a trans-splicing gene therapy platform for liver cancer treatment.

Roche reveals new data on trontinemab and pTau217 testing, aiming to transform Alzheimer’s treatment and diagnosis.

Molecular Devices debuts next-gen SpectraMax microplate readers with improved flexibility and precision for lab assays.

AMSBIO now offers high-purity, lyophilized exosome standards to enhance reproducibility in extracellular vesicle research.

Bio-Rad has introduced four new Droplet Digital PCR platforms, including the QX Continuum™ and QX700™ series. These additions enhance Bio-Rad’s ddPCR offerings with simplified workflows, advanced multiplexing and high throughput.